MESTINON Tablet Ref.[8205] Active ingredients: Pyridostigmine

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2018  Publisher: Mylan Products Ltd, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom

Product name and form

Mestinon 60 mg Tablets.

Pharmaceutical Form

Tablet for oral administration.

White to off-white, round, biplanar, bevel-edged tablets imprinted with “V/M60” across one face and with two break marks forming a cross on the other.

Qualitative and quantitative composition

Each tablet contains 60 mg pyridostigmine bromide.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Pyridostigmine

Pyridostigmine is an antagonist to cholinesterase, the enzyme which normally destroys acetylcholine. The action of pyridostigmine can briefly be described, therefore, as the potentiation of naturally occurring acetylcholine.

List of Excipients

Each tablet contains:

Lactose
Starch
Precipitated silica
Talc
Magnesium stearate
Purified water

Pack sizes and marketing

Amber glass bottles with aluminium screw or low density polyethylene caps and desiccant containing 200 tablets.

Marketing authorization holder

Mylan Products Ltd, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom

Marketing authorization dates and numbers

PL 46302/0133

1 March 1998

Drugs

Drug Countries
MESTINON Austria, Australia, Brazil, Canada, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.